Sun, Dec 21, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Swiss Investment Managers appoints directors, names COO following launch of Directors Dealings Fund

Wednesday, October 12, 2011

Kevin Ryan
Opalesque Industry Update Swiss Investment Managers has appointed Kevin Ryan, Andrew Garai as Non-Executive Directors of the firm. At the same time it has named Melina Panagos as COO and Head of Compliance.

The appointments follow the successful launch of the Directors Dealings Fund, the first and what is believed to be the only hedge fund dedicated to investing based on directors and senior executives own dealings in their firms shares.

Newly-appointed Non-Exec Kevin Ryan is the founder of HedgeDirector Ltd, a provider of expert, independent directors to the hedge fund industry. He was also a founding employee at Financial Risk Management and has more than 18 years of experience in researching and investing in hedge funds.

Joining him on the board is Andrew Garai, who co-founded and acted as Managing Director of Trafalgar Capital Advisors and who brings with him almost three decades of experience with Dresdner Bank, Bear Stearns, LCF Edmond de Rothschild Securities and Fidelity Brokerage. Melina Panagos joins SIM bringing with her two decades of both operational and investment banking experience having previously held senior positions at ANZ Investment Bank, ABN Amro Bank and Greek-listed OTE SA, and Petzetakis SA. She will be responsible for operational and compliance control and risk management at the firm.

Having independent non-executive directors and skilled operational staff is fundamental to both meeting investor comfort level as well as ensuring transparency of investment processes across the firm. So we are pleased to have these highly capable and experienced professionals on board. said Athanasios Ladopoulos, Partner at SIM and Senior Fund Manager of the Directors Dealings fund.

(press release)


Swiss Investment Managers GmbH (SIM) is an alternative investment trading firm, specialising in identifying, profiling, analysing and advising on investing in European and US equities. SIM uses a proprietary investment methodology focused entirely on companies Directors and Senior Executives share transactions. Founded in 2010, SIM is located in Zug, Switzerland, and has an office in Zurich,. SIM has set up and is the Investment Advisor of the Directors Dealings Fund (DD Fund), registered under CSSF in Luxembourg. The DD Fund is the only fund in the world that exclusively employs the Directors Dealings methodology.


See our recent article on the fund:
12.09.2011 Opalesque Exclusive: New Swiss hedge fund endorses the wisdom of following 'the vital few' but not blindly Source

BG

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und